Pulmonary

Navigating Complexity in Pulmonary Trials: Biomarker-Driven Approaches

Exec. Director of Strategy Paul Johnson discusses biomarker-driven approaches for complex pulmonary trials.

July 2, 2026
View the Post

Navigating Complexity in Pulmonary Trials: Enrichment Strategies

PharPoint’s Exec. Dir. of Strategy Paul Johnson discusses the use of enrichment strategies in complex pulmonary trials.

July 2, 2026
View the Post

Navigating Complexity in Pulmonary Trials: Using Adaptive Trial Designs

PharPoint’s Exec. Dir. of Strategy Paul Johnson discusses the use of adaptive trial design for complex pulmonary trials.

July 2, 2026
View the Post

Navigating Complexity in Pulmonary Trials | PharPOV Series

Exec. Dir. Strategy Development Paul Johnson kicks off the first article in a series on pulmonary trial design.

July 2, 2026
View the Post